文献詳細
文献概要
今月の特集1 骨髄不全症の病態と検査
—再生不良性貧血—再生不良性貧血におけるクローン性造血
著者: 牧島秀樹1
所属機関: 1京都大学大学院医学研究科腫瘍生物学講座
ページ範囲:P.740 - P.747
文献購入ページに移動Point
●再生不良性貧血(AA)は自己免疫反応に起因する骨髄不全症候群であり,腫瘍性病変ではない.しかしながら,本症の低形成骨髄はクローナルな細胞集団によって構成されている.
●AAに伴うクローン性造血は,古典的なX染色体のskewingの発見にはじまり,発作性夜間ヘモグロビン尿症(PNH)様血球の検出,さらにはコピー数解析によるUPD6pの発見および次世代シーケンスによる遺伝子変異の検出により証明された.
●AAは骨髄異形成症候群(MDS)など腫瘍性疾患へしばしば移行するが,両者のゲノム異常は明らかに異なる.血液疾患のない高齢者に認められるクローン造血とは一部共通性はあるものの,やはり異なったゲノム異常を呈する.
●AAの原因である自己免疫反応に曝露された骨髄細胞が,そこからエスケープすることによってクローン性造血が生じる.
●再生不良性貧血(AA)は自己免疫反応に起因する骨髄不全症候群であり,腫瘍性病変ではない.しかしながら,本症の低形成骨髄はクローナルな細胞集団によって構成されている.
●AAに伴うクローン性造血は,古典的なX染色体のskewingの発見にはじまり,発作性夜間ヘモグロビン尿症(PNH)様血球の検出,さらにはコピー数解析によるUPD6pの発見および次世代シーケンスによる遺伝子変異の検出により証明された.
●AAは骨髄異形成症候群(MDS)など腫瘍性疾患へしばしば移行するが,両者のゲノム異常は明らかに異なる.血液疾患のない高齢者に認められるクローン造血とは一部共通性はあるものの,やはり異なったゲノム異常を呈する.
●AAの原因である自己免疫反応に曝露された骨髄細胞が,そこからエスケープすることによってクローン性造血が生じる.
参考文献
1)Negoro E, Nagata Y, Clemente MJ, et al:Origins of myelodysplastic syndromes after aplastic anemia. Blood 130:1953-1957,2017
2)Young NS, Maciejewski J:The pathophysiology of acquired aplastic anemia. N Engl J Med 336:1365-1372,1997
3)Young NS:Acquired aplastic anemia. Ann Intern Med 136:534-546,2002
4)Murakami Y, Kosaka H, Maeda Y, et al:Inefficient response of T lymphocytes to glycosylphosphatidylinositol anchor-negative cells: implications for paroxysmal nocturnal hemoglobinuria. Blood 100:4116-4122,2002
5)Gargiulo L, Papaioannou M, Sica M, et al:Glycosylphosphatidylinositol-specific, CD1d-restricted T cells in paroxysmal nocturnal hemoglobinuria. Blood 121:2753-2761,2013
6)Mathé G, Amiel JL, Schwarzenberg L, et al:Bone marrow graft in man after conditioning by antilymphocytic serum. Br Med J 2:131-136,1970
7)Marsh JC, Ball SE, Cavenagh J, et al:Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol 147:43-70,2009
8)Scheinberg P, Young NS:How I treat acquired aplastic anemia. Blood 120:1185-1196,2012
9)Zoumbos NC, Gascón P, Djeu JY, et al:Circulating activated suppressor T lymphocytes in aplastic anemia. N Engl J Med 312:257-265,1985
10)Katagiri T, Qi Z, Ohtake S, et al:GPI-anchored protein-deficient T cells in patients with aplastic anemia and low-risk myelodysplastic syndrome: implications for the immunopathophysiology of bone marrow failure. Eur J Haematol 86:226-236,2011
11)Hinterberger W, Adolf G, Aichinger G, et al:Further evidence for lymphokine overproduction in severe aplastic anemia. Blood 72:266-272,1988
12)Jerez A, Clemente MJ, Makishima H, et al:STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients. Blood 122:2453-2459,2013
13)Koskela HL, Eldfors S, Ellonen P, et al:Somatic STAT3 mutations in large granular lymphocytic leukemia. N Engl J Med 366:1905-1913,2012
14)Jerez A, Clemente MJ, Makishima H, et al:STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. Blood 120:3048-3057,2012
15)Socié G, Henry-Amar M, Bacigalupo A, et al:Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med 329:1152-1157,1993
16)Najean Y, Haguenauer O:Long-term (5 to 20 years) Evolution of nongrafted aplastic anemias. The Cooperative Group for the Study of Aplastic and Refractory Anemias. Blood 76:2222-2228,1990
17)Tisdale JF, Maciejewski JP, Nuñez O, et al:Late complications following treatment for severe aplastic anemia (SAA) with high-dose cyclophosphamide (Cy): follow-up of a randomized trial. Blood 100:4668-4670,2002
18)Dameshek W:Riddle: what do aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH) and “hypoplastic” leukemia have in common?. Blood 30:251-254,1967
19)Josten KM, Tooze JA, Borthwick-Clarke C, et al:Acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria: studies on clonality. Blood 78:3162-3167,1991
20)Griscelli-Bennaceur A, Gluckman E, Scrobohaci ML, et al:Aplastic anemia and paroxysmal nocturnal hemoglobinuria: search for a pathogenetic link. Blood 85:1354-1363,1995
21)Katagiri T, Sato-Otsubo A, Kashiwase K, et al:Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia. Blood 118:6601-6609,2011
22)Mikhailova N, Sessarego M, Fugazza G, et al:Cytogenetic abnormalities in patients with severe aplastic anemia. Haematologica 81:418-422,1996
23)Wang H, Chuhjo T, Yasue S, et al:Clinical significance of a minor population of paroxysmal nocturnal hemoglobinuria-type cells in bone marrow failure syndrome. Blood 100:3897-3902,2002
24)Zaimoku Y, Takamatsu H, Hosomichi K, et al:Identification of an HLA class I allele closely involved in the autoantigen presentation in acquired aplastic anemia. Blood 129:2908-2916,2017
25)Afable MG 2nd, Wlodarski M, Makishima H, et al:SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes. Blood 117:6876-6884,2011
26)Vago L, Perna SK, Zanussi M, et al:Loss of mismatched HLA in leukemia after stem-cell transplantation. N Engl J Med 361:478-488,2009
27)Villalobos IB, Takahashi Y, Akatsuka Y, et al:Relapse of leukemia with loss of mismatched HLA resulting from uniparental disomy after haploidentical hematopoietic stem cell transplantation. Blood 115:3158-3161,2010
28)Shichishima T, Noji H, Ikeda K, et al:The frequency of HLA class I alleles in Japanese patients with bone marrow failure. Haematologica 91:856-857,2006
29)Issaragrisil S, Kaufman DW, Anderson T, et al:The epidemiology of aplastic anemia in Thailand. Blood 107:1299-1307,2006
30)Montané E, Ibáñez L, Vidal X, et al:Epidemiology of aplastic anemia: a prospective multicenter study. Haematologica 93:518-523,2008
31)Imi T, Katagiri T, Hosomichi K, et al:Sustained clonal hematopoiesis by HLA-lacking hematopoietic stem cells without driver mutations in aplastic anemia. Blood Adv 2:1000-1012,2018
32)Lane AA, Odejide O, Kopp N, et al:Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia. Leukemia 27:968-971,2013
33)Kulasekararaj AG, Jiang J, Smith AE, et al:Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome. Blood 124:2698-2704,2014
34)Yoshizato T, Dumitriu B, Hosokawa K, et al:Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia. N Engl J Med 373:35-47,2015
35)Busque L, Patel JP, Figueroa ME, et al:Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis. Nat Genet 44:1179-1181,2012
36)Xie M, Lu C, Wang J, et al:Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat Med 20:1472-1478,2014
掲載誌情報